Zobrazeno 1 - 10
of 141
pro vyhledávání: '"Chih Sheng Chu"'
Autor:
Yi-Kong Chen, Chih-Sheng Chu, Sheng-Wen Niu, Hugo You-Hsien Lin, Pei-Hua Yu, Feng-Ching Shen, Yu-Lin Chao, I-Ching Kuo, Chi-Chih Hung, Jer-Ming Chang
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-9 (2023)
Abstract Kt/V and URR (urea reduction ratio) measurements represent dialysis adequacy. Single-pool Kt/V is theoretically a superior method and is recommended by the Kidney Disease Outcomes Quality Initiative guidelines. However, the prognostic value
Externí odkaz:
https://doaj.org/article/5a7c909b696b405fbbaccc974dd4a944
Autor:
Chao‐Hung Chen, Liang‐Yin Ke, Hua‐Chen Chan, Chih‐Sheng Chu, An‐Sheng Lee, Kun‐Der Lin, Mei‐Yueh Lee, Pi‐Jung Hsiao, Chu‐Huang Chen, Shyi‐Jang Shin
Publikováno v:
Journal of Diabetes Investigation, Vol 11, Iss 3, Pp 535-544 (2020)
Abstract Aims/Introduction Electronegative low‐density lipoprotein (L5) is the most atherogenic fraction of low‐density lipoprotein and is elevated in people with metabolic syndrome (MetS), whereas the retinol‐binding protein 4 receptor (stimul
Externí odkaz:
https://doaj.org/article/5e6df0862d0f46129cbbc79c64e2ef23
Autor:
Wen-Han Feng, Yong-Chieh Chang, Yi-Hsiung Lin, Hsiao-Ling Chen, Chun-Yin Chen, Tsung-Han Lin, Tzu-Chieh Lin, Ching-Tang Chang, Hsuan-Fu Kuo, Hsiu-Mei Chang, Chih-Sheng Chu
Publikováno v:
Pharmaceuticals, Vol 16, Iss 2, p 232 (2023)
P2Y12 inhibitor monotherapy is a feasible alternative treatment for patients after percutaneous coronary intervention (PCI) in the modern era. Clinical trials have shown that it could lower the risk of bleeding complications without increased ischemi
Externí odkaz:
https://doaj.org/article/20e4e9e5d2fc40fb958f0683dc6780d1
Autor:
Sung-Nien Yu, I-Mei Lin, San-Yu Wang, Yi-Cheng Hou, Sheng-Po Yao, Chun-Ying Lee, Chai-Jan Chang, Chih-Sheng Chu, Tsung-Hsien Lin
Publikováno v:
Sensors, Vol 22, Iss 22, p 8771 (2022)
Negative and positive emotions are the risk and protective factors for the cause and prognosis of hypertension. This study aimed to use five photoplethysmography (PPG) waveform indices and affective computing (AC) to discriminate the emotional states
Externí odkaz:
https://doaj.org/article/4d17bd9c70ae40dc81925b228f3dfce1
Autor:
Ching-Tang Chang, MD, Wen-Hsien Lee, MD, Hsuan-Fu Kuo, MD, Mark Z. Chen, PhD, Po-Chao Hsu, MD, Chih-Sheng Chu, MD, Ho-Ming Su, MD, Tsung-Hsien Lin, MD, Hsueh-Wei Yen, MD, Cheng-An Chiu, MD
Publikováno v:
JACC: Case Reports, Vol 1, Iss 5, Pp 792-795 (2019)
Stumpless chronic total occlusion is associated with a higher failure rate of recanalization. Intravascular ultrasound (IVUS) is useful for identifying the entry point; however, 8-F guide catheters are necessary for real-time IVUS-guided wiring. This
Externí odkaz:
https://doaj.org/article/f8f640c1f4af494cafd0a2fe3d1a93ee
Autor:
Chao-Hung Chen, Liang-Yin Ke, Hua-Chen Chan, An-Sheng Lee, Kun-Der Lin, Chih-Sheng Chu, Mei-Yueh Lee, Pi-Jung Hsiao, Chin Hsu, Chu-Huang Chen, Shyi-Jang Shin
Publikováno v:
Journal of Lipid Research, Vol 57, Iss 8, Pp 1435-1446 (2016)
Dyslipidemia has been proven to capably develop and aggravate chronic kidney disease. We also report that electronegative LDL (L5) is the most atherogenic LDL. On the other hand, retinoic acid (RA) and RA receptor (RAR) agonist are reported to be ben
Externí odkaz:
https://doaj.org/article/fd524eded23d4739b5e3e9519fec57e5
Autor:
Hua-Chen Chan, Liang-Yin Ke, Hsiao-Ting Lu, Shih-Feng Weng, Hsiu-Chuan Chan, Shi-Hui Law, I-Ling Lin, Chuan-Fa Chang, Ye-Hsu Lu, Chu-Huang Chen, Chih-Sheng Chu
Publikováno v:
Biomedicines, Vol 8, Iss 12, p 542 (2020)
High-density lipoprotein (HDL) plays a vital role in lipid metabolism and anti-inflammatory activities; a dysfunctional HDL impairs cholesterol efflux pathways. To understand HDL’s role in patients with Alzheimer’s disease (AD), we analyzed the c
Externí odkaz:
https://doaj.org/article/987d9507f12b4731a151cf5af3292899
Autor:
Liang-Yin Ke, Shi Hui Law, Vineet Kumar Mishra, Farzana Parveen, Hua-Chen Chan, Ye-Hsu Lu, Chih-Sheng Chu
Publikováno v:
Biomedicines, Vol 8, Iss 12, p 550 (2020)
Dysregulation of glucose and lipid metabolism increases plasma levels of lipoproteins and triglycerides, resulting in vascular endothelial damage. Remarkably, the oxidation of lipid and lipoprotein particles generates electronegative lipoproteins tha
Externí odkaz:
https://doaj.org/article/93ae58ce8fb848a1a36333855af6e57e
Autor:
Chih-Sheng Chu, Shi Hui Law, David Lenzen, Yong-Hong Tan, Shih-Feng Weng, Etsuro Ito, Jung-Chou Wu, Chu-Huang Chen, Hua-Chen Chan, Liang-Yin Ke
Publikováno v:
Biomedicines, Vol 8, Iss 8, p 254 (2020)
Despite the numerous risk factors for atherosclerotic cardiovascular diseases (ASCVD), cumulative evidence shows that electronegative low-density lipoprotein (L5 LDL) cholesterol is a promising biomarker. Its toxicity may contribute to atherothrombot
Externí odkaz:
https://doaj.org/article/2501fc44a0f043fbae3d3b48c6c6f177
Autor:
An-Sheng Lee, Chao-Hung Chen, Kun-Der Lin, Hua-Chen Chan, Chih-Sheng Chu, Pi-Jung Hsiao, Mei-Yueh Lee, Shyi-Jang Shin, Liang-Yin Ke, Chu-Huang Chen
Publikováno v:
Journal of Diabetes Investigation, Vol 11, Iss 3, Pp 535-544 (2020)
Journal of Diabetes Investigation
Journal of Diabetes Investigation
Aims/Introduction Electronegative low‐density lipoprotein (L5) is the most atherogenic fraction of low‐density lipoprotein and is elevated in people with metabolic syndrome (MetS), whereas the retinol‐binding protein 4 receptor (stimulated by r